CD4 and anal carcinoma: Up to five controls were selected among patients with no history of anal cancer, followed at the time of anal cancer diagnosis (index date), matched with the case for age (±three years), sex transmission group, centre, CD4 and viral load (VL) at index date and period of inclusion in FHDH (before 1997 or after 1997).